Skip to main content

Sunday Night Football Recap: Top Stories, Sports and Business News — Sept. 14

Publish date:
Video Duration:

These are the stories shaping sports and business on Monday, Sept. 14, 2020.

Sunday Night Football

It was the first NFL Sunday of the season but also the first time the Patriots won and Tom Brady lost in the same weekend since October 1999.

Brady’s debut with the Buccaneers didn’t go so well as he threw two picks, including a pick six, which he’s now done in three straight games, in a loss to the Saints. 

Read more: Time Has Finally Caught up with Tom Brady: Unchecked

Daily Coronavirus Update

According to Johns Hopkins, there are over 29 million cases of the virus worldwide, with over 924,000 deaths. The U.S. has surpassed 6.5 million cases with 194,000 deaths.

This morning, TheStreet’s Katherine Ross spoke to Raymond James biotech analyst Steven Seedhouse about the road to a vaccine and his thoughts about the AstraZeneca trial halt. He also said that we’re “in the Golden Age of biotech.”

Ross asked him whether or not we should continue to hear vaccine updates from CEOs and he said that it’s “too important” to not know. He also added that it’s impressive to see what has been accomplished so far in the vaccine timeline.

Seedhouse noted that one concern is that the vaccine candidates are not as effective--right now the hurdle that the companies are aiming to get over, he noted, is a 50% effectiveness. So, if the vaccine isn’t as effective, then you can’t just stop wearing masks outside without risk, for example. And another concern is that people won’t get the vaccine when it is released to the general public, because “people just don’t trust the process” but he says that there’s reason for that because at the end of the day, we’re obviously not going to have the long-term safety data because of how fast everyone is moving to create this vaccine.

One other thing to note is that Seedhouse is bearish on remdesivir because the favorable view on remdesivir is that it shortens the time of recovery in patients with COVID-19, but “they’ve never shown a statistical benefit on death in any study.”

DraftKings & ESPN Announce Partnership

ESPN and DraftKings undefined announced a multi-year partnership that makes DraftKings ESPN’s exclusive daily fantasy sports partner.

DraftKings, one of the market leaders in daily fantasy will now be able to integrate its products and offerings across ESPN’s digital platforms and for sure will be featured heavily in television segments on the sports network.

DraftKings stock got an immediate bump following the announcement, jumping more than 10% at last check and trading well ahead of its all-time closing high of $43.70.

DraftKings’ announcement comes just a day ahead of the debut of the Barstool Sports betting app, which will have a state-monitored soft launch starting Tuesday before its debut on Friday.

The DraftKings rival is a product of a similar branding agreement between casino gaming company Penn National and media company Barstool Sports.

So the timing of the announcement is interesting. As the NFL season heats up, apparently so too does the DFS battle.

Latest Videos From TheStreet and Jim Cramer:

Related Videos